The minimal important difference (MID) is the smallest benefit of treatment that would result in clinicians recommending it to their patients.
The MID is necessary to calculate sample size for randomized clinical trials, but its chosen value is often arbitrary.
This study set out to determine the practicability of surveying physicians to elicit the MID for clinical trial sample-size calculation.
Using a mail survey, we elicited the MID of different physician specialties (family medicine, internal medicine, vascular surgery) for using propranolol to slow abdominal aortic aneurysm (AAA) growth assuming that propranolol was efficacious in this condition.
We used different outcome measures (growth rate or proportion of patients requiring surgery) and different methods of data presentation for the proportion of patients requiring surgery (absolute risk reduction or number needed to treat).
The MID varied significantly by physician specialty, experience with AAA and propranolol, and the method used to elicit the MID.
Consequently, sample-size calculations using these various MIDs varied from 116 to 3015.
Future attempts to elicit the MID need to consider carefully who is surveyed, how data are presented, and how opinions are elicited.
Mots-clés Pascal : Essai clinique, Traitement, Chimiothérapie, Propranolol, Bloquant bêta-adrénergique, Antiarythmique, Antagoniste, Récepteur bêta-adrénergique, Taille échantillon, Anévrysme, Aorte abdominale, Epidémiologie, Méthodologie, Calcul statistique, Homme, Canada, Amérique du Nord, Amérique, Médecin, Spécialité médicale, Appareil circulatoire pathologie, Vaisseau sanguin pathologie, Aorte pathologie, Artère pathologie
Mots-clés Pascal anglais : Clinical trial, Treatment, Chemotherapy, Propranolol, Beta blocking agent, Antiarrhythmic agent, Antagonist, bêta-Adrenergic receptor, Sample size, Aneurysm, Abdominal aorta, Epidemiology, Methodology, Statistical computation, Human, Canada, North America, America, Physician, Medical specialty, Cardiovascular disease, Vascular disease, Aortic disease, Arterial disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 99-0467108
Code Inist : 002B30A01A1. Création : 22/03/2000.